Johnson and Johnson gets USFDA accelerated nod for multiple myeloma drug Talvey Ruchika Sharma11 Aug 2023 11:29 AM ISTTALVEY is approved as a weekly or biweekly subcutaneous (SC) injection after an initial step-up phase, offering physicians the flexibility to...
Zydus Lifesciences bags USFDA nod for Plerixafor Injection Ruchika Sharma27 July 2023 3:25 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food and Drug...
Aurobindo Pharma arm bags USFDA nod for Plerixafor Injection Ruchika Sharma25 July 2023 3:55 PM ISTPlerixafor injection is indicated in combination with granulocyte-colony stimulating factor to mobilize hematopoietic stem cells (HSCs) to the...
J&J Gets CDSCO Panel Nod To Market Teclistamab sterile liquid in Vials Dr. Divya Colin7 July 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Johnson and Johnson has got approval from the Subject Expert Committee (SEC) functional under...
Multiple Myeloma: A Comprehensive Guide To The Disease - Dr Ushang Kate Dr Ushang Kate10 Jun 2023 12:39 PM ISTMultiple myeloma (MM) is a relatively rare form of cancer, accounting for approximately 1% of all cancers and 10% of all haematological...
Janssen seeks USFDA nod for Carvykti for relapsed or refractory multiple myeloma Ruchika Sharma8 Jun 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License...
Dr Reddy's Gets CDSCO Panel Nod to Manufacture, Market Anticancer Drug Lenalidomide Capsules Dr. Divya Colin26 May 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Dr. Reddy's Laboratories has got a green signal from the Subject Expert Committee (SEC)...
Can Lamina Cribrosa Indicate Optic Neuritis in Multiple Sclerosis? Dr. Krishna Shah18 March 2023 9:45 AM ISTIn a recent article published in Neurology India, Researchers in Turkey have found that the lamina cribrosa was thinner in Multiple Sclerosis patients...
Natco Pharma rolls out additional strengths for generic version of Revlimid in US Ruchika Sharma10 March 2023 2:15 PM ISTLenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Cancer drug: Aurobindo Pharma arm Eugia Pharma gets USFDA approval for Lenalidomide Capsules Ruchika Sharma9 March 2023 1:15 PM ISTThe approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone.
Multiple Myeloma medicine: Natco Pharma unveils Pomalidomide under brand NAT-POMALIDOMIDE in Canada Ruchika Sharma1 March 2023 12:15 PM ISTMultiple myeloma, commonly referred to as myeloma, is a cancer of plasma cells.
USFDA grants priority review to Pfizer Elranatamab for relapsed or refractory multiple myeloma Ruchika Sharma24 Feb 2023 2:30 PM ISTElranatamab is an investigational, off-the-shelf, humanized BCMA CD3-targeted BsAb.
